Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma
Leonard L, Beaty L, Thomas M, Quinn C, Colborn K, de Araujo T, Torphy R, Assumpção L, Olino K, Studts C, Franco S, McCarter M, Stewart C, Gleisner A. Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma. Journal Of Surgical Oncology 2022, 127: 716-726. PMID: 36453464, DOI: 10.1002/jso.27153.Peer-Reviewed Original ResearchMeSH KeywordsHumansLymph Node ExcisionMelanomaMultilocus Sequence TypingSentinel Lymph NodeSentinel Lymph Node BiopsySkin NeoplasmsConceptsCompletion lymph node dissectionSentinel lymph nodesPositive sentinel lymph nodesLymph node dissectionNode dissectionMultivariable mixed-effects logistic regression modelGovernment-based insuranceNational Cancer DatabasePrimary tumor locationStage III melanomaEffect of patientContribution of patientMixed effects logistic regression modelsLogistic regression modelsTumor factorsOlder patientsSurvival benefitLymph nodesSurgical excisionStandard treatmentTumor locationCancer DatabasePatient variablesPatientsLower limbs